Allogene Therapeutics
Ruth Gozun possesses extensive experience in Environmental Health and Safety (EH&S) and security, holding various leadership roles at Allogene Therapeutics, where responsibilities included Associate Director, Senior Manager, and Manager of EH&S & Security. Prior to this, Ruth was a Project Manager at ERM: Environmental Resources Management and served as an Environmental Health & Safety Engineer at SolarCity, WD (a Western Digital company), and Tesla Motors. This diverse background in the field highlights a strong commitment to environmental and safety management across multiple industries.
This person is not in the org chart
This person is not in any teams
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.